Scinai Immunotherapeutics Ltd.
SEC CIK 1611747 · SCNI · last insider filing 2026-06-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Germain Mark | Director | filed 2023 - 2026 |
| Reichman Amir | Director · Chief Executive Officer | filed 2023 - 2026 |
| Raviv Adi | Director | filed 2023 - 2026 |
| Moed Samuel J | Director | filed 2023 - 2026 |
| Ben-Or Uri | Director · Chief Financial Officer | filed 2023 - 2026 |
| Margolin Yael | Director | filed 2023 - 2026 |
| Green Jay | Director | filed 2023 - 2026 |
| Laster Morris C | Director | filed 2023 - 2023 |
| Rotman Avner | Director | filed 2023 - 2023 |
| Lowell George | Director | filed 2023 - 2023 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Mark Elad | Chief Operating Officer | filed 2023 - 2026 |
| Ben-Yedidia Tamar | Chief Scientist | filed 2023 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.